Patrick Bishop Email & Phone Number

• Currently promoting the Acne/Rosacea line of products - Aklief, Oracea and Epiduo Forte to Dermatologists in the Long Island territory• Appointed Field Trainer for new hires.• Selected to work with and develop Field Coaching Reports for DAS Sales Division. • Compliance Officer for New England District – 2018 -2019• Budget Lead New England District – Collected and advised on budget spending.Achievements• Impact Award – 2018• Impact Award - 2020

•Promoted Sorilux and Veltin to Dermatologists in the Brooklyn/Staten Island/Queens territory.•Selected for the Emerging Leaders Development Program - July 2013•Assisted new hires on both product and data systems training.•Facilitate District conference calls on new product marketing strategies.•Selected for the Sorilux launch Advisory Board Team - 2012•Appointed Managed Market Liaison – 2012•Promoted to Senior Executive Sales Specialist (Grade 8) – May 2011.•Was selected for the Team 2 Advisory Board – 2011•Ranked # 1 in the Nation for Team 2 Eastern Region.•Finished at 127%of goal for all 4 products combined – Extina, Xologel, Soriatane, Duac.•Was selected to be District Sales Trainer for 2009 – Facilitated in training programs by delivering PowerPoint Presentations on the clinical benefits for specific products.•Was trained and certified to promote Enbrel – An injection product indicated for Rheumatoid, and Psoriatic Arthritis, including Plaque Psoriasis – Other products include Olux-E, Soriatane, Extina.•Selected as 1 of 30, out of sales force of 227, to launch new Aesthetic Division.•Opened 25 Revaleskin accounts in the first 3 months of launch. Generating $40K in sales.•Ranked 7th overall in 2005 PRESIDENT’S COUNCIL.•Olux Q1 Goal Attainment - 123% - Regional Rank #1, National Rank #2. (2006)•Olux Q2 Goal Attainment – 120% - Regional Rank #1, National Rank #1.(2006)

•Responsible for promoting Dermatology products to specialists.•Took a leadership role in organizing both Elidel and Ritalin LA educational programs. •Played a major role in developing advocates for Elidel •Set up Elidel educational programs at all Central Long Island Medical Group locations. In the process, played an important role in getting the step-edit procedure removed from the HIP prescription coverage for Elidel.

•Responsible for promoting Allegra/Nasacort AQ to Allergists, and high volume primary care physicians. •2001 Ring Award Winner – 105% of quota.•2002 Ring Award Winner – 114% of quota.•Selected to become a National Sales Trainer – May 2002.•Promoted from Sales Associate to professional Sales Associate – 2002.•Outpaced the Northeast/Mid Atlantic Region for Nasacort AQ. 148% vs. 111% - Q1 2002.